The first stop for professional medicines advice

Sirolimus

Published
Topics: CancersCCG commissioned new medicinesEyes and vision · New MedicinesNHS England commissioned new medicinesPatent expiriesPre-registration new medicines (UK/EU)Respiratory disordersSafety in BreastfeedingSirolimusSkin disordersStability in dosette boxesStability outside the fridge ·
Contents
  1. dm+d
  2. Refrigerated Storage
    1. Rapamune · Pfizer
  3. Medicine Compliance Aid Stability
    1. Rapamune · Pfizer Ltd
  4. Lactation Safety Information

dm+d

116109004

Refrigerated Storage

RapamunePfizer

Pfizer
Rapamune
Oral solution, 1mg/mL

In the event of an inadvertent temperature excursion the following data may be used:

If necessary, the patient may store the bottles at room temperature up to 25°C for a short period of time (24 hours), and then put back in a refrigerator at 2-8°C and use the product within 30 days after opening the bottle.

Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

25 February 2022
London MI Service

Medicine Compliance Aid Stability

RapamunePfizer Ltd

Pfizer Ltd
Rapamune
Tablets coated 500 micrograms, 1mg, 2mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light in an airtight container.
25 October 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Caution
See summary
Long half-life increases risk of accumulation in breastfed infants
Low levels anticipated in milk due to the drug's properties
May interfere with lactation
No published evidence of safety
Monitor infant plasma levels if there is a concern about toxicity
16 September 2020